XML 209 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Income Taxes
12 Months Ended
Jun. 30, 2025
Income Taxes  
Income Taxes

12. Income Taxes

The components of income before income taxes consisted of the following:

For the Year Ended June 30

    

2025

    

2024

    

2023

Domestic

$

3,304

$

(22,820)

$

14,776

Foreign

 

64,689

 

33,736

 

39,295

Income before income taxes

$

67,993

$

10,916

$

54,071

 

Components of the provision for income taxes were:

For the Year Ended June 30

    

2025

    

2024

    

2023

Current provision:

 

  

 

  

 

  

Federal

$

5,557

$

3,037

$

9,801

State and local

 

2,448

 

1,718

 

1,810

Foreign

 

16,477

 

15,740

 

12,750

Total current provision

 

24,482

 

20,495

 

24,361

Deferred provision (benefit):

 

 

 

  

Federal

 

(4,412)

 

(4,755)

 

(6,151)

State and local

 

(1,521)

 

(1,523)

 

(266)

Foreign

 

1,171

 

(4,468)

 

3,424

Change in foreign valuation allowances

 

9

 

(1,249)

 

97

Total deferred benefit

 

(4,753)

 

(11,995)

 

(2,896)

Provision for income taxes

$

19,729

$

8,500

$

21,465

 

Reconciliations of the federal statutory rate to the Company’s effective tax rate were:

For the Year Ended June 30

    

2025

    

2024

    

2023

U.S. federal statutory income tax rate

 

21.0

%  

21.0

%  

21.0

%  

State and local taxes, net of federal benefit

 

0.6

(1.1)

2.0

Taxes on non-U.S. income

 

(0.6)

9.9

8.9

Changes in uncertain tax positions

30.7

5.1

Global Intangible Low-Taxed Income

 

4.7

18.3

3.3

Recognition of federal and foreign tax credits

(13.7)

(10.6)

(3.1)

Change in valuation allowance

(0.1)

(11.4)

0.2

Foreign derived intangible income

(3.8)

(3.7)

Non-U.S. withholding and related taxes, net, on planned repatriation

13.0

28.4

Impact of foreign tax credit regulations and related changes

(20.0)

1.9

Non-deductible operating expenses

2.9

11.3

0.9

Non-deductible acquisition costs

4.3

Other

 

1.1

0.9

3.2

Effective income tax rate

 

29.0

%  

77.9

%  

39.7

%

 

We record the GILTI aspects of comprehensive U.S. income tax legislation as a period expense. The provision for income taxes for the years ended June 30, 2025, 2024 and 2023, included $3,198, $2,003 and $1,775 of federal tax expense from the effects of GILTI, respectively.

The Company benefits from certain tax holidays in Israel; the impact of which are included within Taxes on non-U.S. income.

The tax effects of significant temporary differences that comprise deferred tax assets and liabilities were:

As of June 30

    

2025

    

2024

Deferred tax assets:

Employee-related accruals

$

5,940

$

6,620

Inventory

 

10,681

 

1,521

Environmental remediation

 

783

 

767

Net operating loss carry forwards–domestic

 

689

 

777

Net operating loss carry forwards–foreign

 

2,705

 

3,813

Operating lease liabilities

8,399

6,788

R&D cost capitalization

8,647

7,227

Unrealized foreign exchange

1,470

Interest expense limitation

3,900

4,518

Accrued expenses

11,001

5,535

Acquisition related expenses

2,161

1,167

Other

4,703

 

522

 

59,609

 

40,725

Valuation allowance

 

(1,279)

 

(1,288)

 

58,330

 

39,437

Deferred tax liabilities:

 

 

Property, plant and equipment and intangible assets

(18,989)

(5,282)

Operating lease ROU assets

(7,939)

(6,441)

Prepaid expenses

(1,728)

(1,505)

Unrealized foreign exchange

(1,601)

Non-U.S. withholding and related taxes, net, on planned repatriation

(250)

(2,828)

Other

 

(6,472)

 

(4,677)

 

(36,979)

 

(20,733)

Net deferred tax asset

$

21,351

$

18,704

 

Deferred taxes are included in the consolidated balance sheets as follows:

As of June 30

    

2025

    

2024

Other assets

$

25,548

$

19,371

Other liabilities

 

(4,197)

 

(667)

$

21,351

$

18,704

 

The valuation allowance established against deferred tax assets was:

As of June 30

    

2025

    

2024

    

2023

Balance at beginning of period

$

1,288

$

2,598

$

2,618

Benefit for income taxes

(9)

 

(1,310)

 

(20)

Balance at end of period

$

1,279

$

1,288

$

2,598

 

The Company records valuation allowances against certain foreign and state deferred tax assets when, after considering all of the available evidence, it is more likely than not that these assets will not be realized.

The Company has $18,748 of state net operating loss carry forwards, of which $11,359 that will expire in 2025 through 2044, and $7,389 that do not expire. The Company has $11,598 of foreign net operating loss carry forwards primarily in jurisdictions that have no expiration.

If amounts are repatriated from certain of our foreign subsidiaries, we could be subject to additional non-U.S. income and withholding taxes. In connection with the Acquisition (see Note 3), we expect to repatriate approximately $5,000 of non-U.S. earnings, which will be subject to applicable non-U.S. withholding and related taxes. As of June 30, 2025, we recorded a liability of $250 related to undistributed earnings of our Suzhou subsidiary in China. We consider all other undistributed earnings of such foreign subsidiaries to be indefinitely reinvested. We do not provide income taxes for foreign currency translation adjustments relating to investments in international subsidiaries that will be held indefinitely.

As tax law is complex and often subject to varied interpretations, it is uncertain whether some of our tax positions will be sustained upon examination. Tax liabilities associated with uncertain tax positions represent unrecognized tax benefits, which arise when the estimated benefit recorded in our financial statements differs from the amounts taken or expected to be taken in a tax return because of the uncertainties described above. Substantially all of these unrecognized tax benefits, if recognized, would reduce our effective income tax rate.

Reconciliations of the beginning and ending amounts of gross unrecognized tax benefits are as follows:

As of June 30

    

2025

    

2024

    

2023

Unrecognized tax benefits–beginning of period

$

11,861

$

9,449

$

7,832

Tax position changes–current period

 

(809)

 

2,066

 

2,181

Tax position changes–prior periods, including settlements with tax authorities

 

541

 

615

 

193

Lapse of statute of limitations

 

(637)

 

(58)

 

(194)

Effect of changes in exchange rates

 

1,514

 

(211)

 

(563)

Unrecognized tax benefits–end of period

 

12,470

 

11,861

 

9,449

Interest and penalties–end of period

 

2,804

 

1,689

 

981

Total liabilities related to uncertain tax positions

$

15,274

$

13,550

$

10,430

 

We recognize interest and penalties associated with uncertain tax positions as a component of the provision for income taxes. We recognized and recorded interest and penalties expense of $888, $740 and $589 for 2025, 2024 and 2023, respectively.

Income tax returns for the following periods are no longer subject to examination by the relevant tax authorities:

U.S. federal and significant states, through June 30, 2021;
Brazil, through December 31, 2019; and
Israel, through June 30, 2020.

On July 4, 2025, the United States enacted “An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14,” (“OBBBA”), also known as the “One Big Beautiful Bill Act.,” OBBBA made significant changes to the Internal Revenue Code, including the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions such as 100% bonus depreciation, domestic research cost expensing, and adjusting the business interest expense limitation.

OBBBA has multiple effective dates, with certain international tax provisions not impacting the Company until July 1, 2026. The Company is currently evaluating the potential impact of this legislation on its consolidated financial statements. Any material effects of OBBBA, including remeasurement of deferred tax assets and liabilities and changes to current and future tax expense, will be reflected in the period of enactment and in future periods as additional guidance is issued and the Company completes its analysis.